State Of Wyoming Sage Therapeutics, Inc. Transaction History

State Of Wyoming

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$27.52 - $37.99 $77,303 - $106,713	-2,809 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$30.71 - $45.71 $9,028 - $13,438	-294 Reduced 9.47%	2,809 $93,000
Q4 2021 Feb 11, 2022	BUY	$37.06 - $47.11 $60,815 - $77,307	1,641 Added 112.24%	3,103 $132,000
Q3 2021 Feb 11, 2022	SELL	$40.26 - $57.37 $119,692 - $170,561	-2,973 Reduced 67.03%	1,462 $65,000
Q2 2021 Feb 14, 2022	BUY	$54.88 - $79.29 $154,871 - $223,756	2,822 Added 174.95%	4,435 $252,000

Q2 2021 Feb 11, 2022	BUY	$54.88 - $79.29 $88,521 - $127,894	1,613 New	1,613 $92,000

223

52.7M

207K

191K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $645M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

Stay updated on State Of Wyoming with notifications on news.